Table of contents
July 2004 Vol 4 No 7
In this issue
p495 | doi:10.1038/nrc1406
Research Highlights
Targeted therapy: Mapping specific access
p497 | doi:10.1038/nrc1399
Cancer stem cells: Self-renewal
p498 | doi:10.1038/nrc1397
In the news
Statins branch out
p498 | doi:10.1038/nrc1401
Tumour suppressors: Happy couple
p498 | doi:10.1038/nrc1402
In brief
Carcinogenesis | Gene Expression | Angiogenesis | Breast Cancer
p499 | doi:10.1038/nrc1400
Chromosome instability: Too much of a good thing
p500 | doi:10.1038/nrc1395
Diagnosis: Time for a change
p500 | doi:10.1038/nrc1398
Tumour progression: Invasion suppressed
p501 | doi:10.1038/nrc1396
Gene therapy: Special delivery
p502 | doi:10.1038/nrc1394
Tumour suppressors: The PUMA effect
p502 | doi:10.1038/nrc1403
Trial Watch
Normal PSA, but still get prostate cancer | Hope for kidney cancer
p503 | doi:10.1038/nrc1404
Tumour suppressors: Discrimination
p503 | doi:10.1038/nrc1407
Reviews
Insulin-like growth factors and neoplasia
Michael N. Pollak, Eva S. Schernhammer & Susan E. Hankinson
p505 | doi:10.1038/nrc1387
The multiethnic cohort study: exploring genes, lifestyle and cancer risk
Laurence N. Kolonel, David Altshuler & Brian E. Henderson
p519 | doi:10.1038/nrc1389
Hyaluronan: from extracellular glue to pericellular cue
Bryan P. Toole
p528 | doi:10.1038/nrc1391
Cancer and the chemokine network
Fran Balkwill
p540 | doi:10.1038/nrc1388
Metabolic profiles of cancer cells
Julian L. Griffin & John P. Shockcor
p551 | doi:10.1038/nrc1390
Perspective
Opinion
Analysis of genomic targets reveals complex functions of MYC
Jagruti H. Patel, Andrey P. Loboda, Michael K. Showe, Louise C. Showe & Steven B. McMahon
p562 | doi:10.1038/nrc1393